key: cord-0916099-wprnxnhm
authors: Nawwar, Ayah Adel; Searle, Julie; Hagan, Ian; Lyburn, Iain Douglas
title: Systemic Immune Response Syndrome After COVID-19 Immunization—Initial and Follow-up (18)F-FDG PET/CT Imaging Appearances
date: 2022-01-13
journal: Clin Nucl Med
DOI: 10.1097/rlu.0000000000004032
sha: e3ea7edc4259fa4dbcceccfdbae06e5cb5e24fc6
doc_id: 916099
cord_uid: wprnxnhm

A 46-year-old woman with previous history of breast cancer had follow-up (18)F-FDG PET/CT 5 days after COVID-19 vaccination. In addition to avid axillary nodes, a well-documented feature, the scan demonstrated diffuse splenic and marrow uptake. Clinical history, laboratory, and scan findings were in keeping with SIRS (systemic inflammatory response). The patient recovered with supportive management. On follow-up, (18)F-FDG PET/CT imaging 3 months later features had resolved. SIRS after vaccination may be observed on (18)F-FDG PET/CT.

; the small volume avid left axillary nodes, left deltoid uptake, and diffuse splenic and marrow uptake have resolved, consistent with the working diagnosis of SIRS related to COVID-19 vaccination. Although not a common response to vaccination, given the world wide mass immunization programs and the potential of recurrent seasonal boosters, SIRS may be observed with increasing frequency on 18 F-FDG PET/CT. In conjunction with the appropriate clinical history and laboratory findings, the diagnosis of SIRS should be considered if FDG uptake is demonstrated in the superficial aspect of the deltoid muscle, ipsilateral axillary nodes, and diffusely within the spleen and bone marrow. Focal uptake in the left upper arm/deltoid most correlates to the injection site, and the avid small volume left axillary nodes are in keeping with being reactive. These vaccine-associated reactive findings are well documented. [1] [2] [3] [4] [5] [6] Physiological splenic uptake is expected to be similar or less to liver background. 7 Elevated diffuse splenic and bone marrow uptake may be seen in a number of scenarios, such as iatrogenic (eg, granulocyte colony-stimulating factor), anemia, or systemic inflammatory/infectious diseases. [8] [9] [10] The patient was unwell the day after vaccination, presenting with persistent high fever. Iatrogenic causes were excluded. She was admitted for observation, investigations, and supportive treatment. Persistent fever was recorded at 38.4°C, mild tachycardia (99 beats per minute), and lymphopenia (3200/mm 3 ), criteria in support of systemic inflammatory response syndrome (SIRS). Sepsis was excluded by negative serial blood cultures. The patient recovered on supportive treatment. The presentation and 18 F-FDG PET/CT findings were in keeping with vaccination-related SIRS. A similar case was described with influenza vaccination in 2016 and very recently with an m-RNA COVID-19 and Oxford-AstraZeneca COVID-19 vaccinations. [10] [11] [12] 

COVID-19 vaccination induced axillary nodal uptake on [ 18 F]FDG PET/CT

COVID-19 vaccinationrelated uptake on FDG PET/CT: an emerging dilemma and suggestions for management

Axillary lymph nodes hypermetabolism after BNT162b2 mRNA COVID-19 vaccination in cancer patients undergoing 18 F-FDG PET/CT: a cohort study

COVID-19 vaccination-associated lymphadenopathy on FDG PET/CT: distinctive features in adenovirusvectored vaccine

18 F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact

Effects of COVID-19 vaccination on FDG-PET/CT imaging: a literature review

Diffuse splenic uptake

Clinical significance of diffusely increased splenic uptake on FDG-PET

Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results

Systemic immune response to vaccination on FDG-PET/CT

18 F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine

Features of systemic immune response from COVID-19 vaccination on 18 F-FDG PET/CT